Table: Taiko Pharmaceutical -2022 parent results

Taiko Pharmaceutical

10/02/2023 06:30

Feb 10 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended       Year to     NEXT     
               Dec 31, 2022     Dec 31, 2021   Dec 31, 2023     YEAR     
                  LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales            4.64            10.60                                 
  Operating     loss 2.96        loss 5.02                               
  Recurring     loss 3.27        loss 5.86                               
  Net           loss 4.95        loss 9.27                               
  EPS        loss 113.64 yen  loss 213.03 yen                            
  Ann Div          NIL              NIL                                  
  -Q2 Div          NIL              NIL                                  
  -Q4 Div          NIL              NIL                                  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T